ProPhase Labs Added to the Russell Microcap Index
GARDEN CITY, NY, June 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (ProPhase or the Company), a diversified medical science and technology company, today announces that it has been added to the Russell Microcap Index.
- GARDEN CITY, NY, June 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (ProPhase or the Company), a diversified medical science and technology company, today announces that it has been added to the Russell Microcap Index.
- Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
- FTSE Russell determines membership for its Russell Indexes primarily by objective, market-capitalization rankings and style attributes.
- Russell Indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.